2009
DOI: 10.1016/j.bmc.2008.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Interaction between double helix DNA fragments and a new topopyrone acting as human topoisomerase I poison

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…[35,52] A linear correlation of log(D) values versus log(M w ) was derived by using different standards. [53] The GL3 siRNA was also included as an additional standard. Linear least-squares fitting was achieved by using Equation (11), with a correlation coefficient R 2 of 0.9947. logðDÞ ¼ À0:4333 Â logðM w ÞÀ8:1987 ð11Þ…”
Section: Nmr Experimentsmentioning
confidence: 99%
“…[35,52] A linear correlation of log(D) values versus log(M w ) was derived by using different standards. [53] The GL3 siRNA was also included as an additional standard. Linear least-squares fitting was achieved by using Equation (11), with a correlation coefficient R 2 of 0.9947. logðDÞ ¼ À0:4333 Â logðM w ÞÀ8:1987 ð11Þ…”
Section: Nmr Experimentsmentioning
confidence: 99%
“…The power for classification of BCPs by anti-TOP-I activity was 0.87–0.93 for total accuracy and 0.22 for cross-validation error. Moreover, the final SVM model was applied to classify a set of 10 BCP analogues recently synthesized by Lavoie et al , which so-called application set or external test set 2 and detailed chemical structures and TOP-I activities are shown in Table 5 [ 22 , 23 , 24 , 25 , 26 ]. According to literature, among these 10 BCP analogues, seven compounds have stronger anti-TOP-I activity than topotecan and three compounds are weaker than topotecan.…”
Section: Resultsmentioning
confidence: 99%
“…The linearly fused topopyrones B and D are especially potent, and indeed, the activity of 53 against topo-I appears to be comparable to that of camptothecin [9091 100101]. Accordingly, our research centered on the linear series of compounds.…”
Section: Reviewmentioning
confidence: 99%